Clarification re Directorate Change (7204W)
February 02 2012 - 10:58AM
UK Regulatory
TIDMHLO
RNS Number : 7204W
Healthcare Locums PLC
02 February 2012
Earlier today the Company announced the appointment of Sue
Bygrave as Chief Finance Officer (Designate). This press release is
being reissued owing to an incorrect date in the original version
of the table showing past directorships. The dates have now been
corrected and the full text of the announcement is printed
below.
Healthcare Locums plc
("HCL" or the "Company")
Directorate Change - Amendment
Appointment of Chief Finance Officer (Designate)
The Board of Healthcare Locums plc, a leading provider of
staffing solutions in the health and social care sectors, is
pleased to announce the appointment of Sue Bygrave, 46, as Chief
Finance Officer (Designate), succeeding Bill Jessup, Interim Chief
Finance Officer who will step down on publication of the financial
accounts for the year ended 31 December 2011. Sue will formally
take up her role as an Executive Director on the Board of HCL on 6
February 2012 and will assume responsibility for all accounting
activity across the Group including operations in Australia.
Sue joins from Biome Technologies plc, the AIM listed
bioplastics and RF (radio frequency) technology business, where she
was Group Finance Director supporting an acquisition strategy
whilst driving organic growth. Prior to Biome Technologies, Sue was
Group Finance Director of VEGA Group plc, an organisation
delivering consulting, technology and managed solutions into
Aerospace, Defence and Government Markets. She was Joint Chair of
the Executive Management Team that saw the repositioning of the
business as an independent specialist services company prior to its
acquisition by Finmeccanica in 2008.
Sue is an ACA qualified accountant and began her career with
KPMG in Audit.
Peter Sullivan, Chairman of HCL, commented: "We are delighted
that Sue is joining the company as Chief Finance Officer. She
brings with her a wealth of experience which will be invaluable to
the business as we continue to transform the organisation. We look
forward to welcoming her to the Board."
Sue holds or has held directorships in the five years preceding
her appointment at HCL as follows:
Current directorships and Past directorships and partnerships
partnerships
-------------------------- --------------------------------------------
None Biome Technologies plc (Jan 2009-Oct
2011)
-------------------------- --------------------------------------------
VEGA Group plc (Nov 2004-Feb 2008)
-------------------------- --------------------------------------------
Mettoni Group plc (placed into receivership
July 2002, dissolved April 2009)
-------------------------- --------------------------------------------
There are no further disclosures to be made with regards to this
appointment under paragraph (g) of Schedule 2 of the AIM Rules.
Ends
For further information please contact:
Healthcare Locums plc
Stephen Burke, Chief Executive Officer
020 7451 1451
Investec Bank plc
Gary Clarence/Patrick Robb/Daniel Adams
020 7597 5970
Pelham Bell Pottinger
David Rydell/Emma Kent/Duncan Mayall/Charlotte Offredi
020 7861 3233
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOABKBDQPBKDOBK
Healthcare Locums (LSE:HLO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Healthcare Locums (LSE:HLO)
Historical Stock Chart
From Sep 2023 to Sep 2024